Abstract
Purpose
The aim of this study was to compare quality of life (QoL) data from cancer patients in different clinical settings with data from the general population.
Methods
A sample of 4020 German cancer patients (1735 inpatients, 1324 outpatients, 961 participants in rehabilitation treatment) was tested with the EORTC QLQ-C30.
Results
Compared with the general population, cancer patients reported markedly worse QoL. There were clinically significant differences on all 15 scales of the EORTC QLQ-C30 (except one). For the sum score, averaging across 13 scales, the effect size of the difference between cancer patients and the general population was d = 1.16. Inpatients reported the greatest detriments to QoL, followed by the rehabilitation patients and the outpatients (mean sum scores 68.6, 71.0, and 72.3, respectively, compared with 89.2 in the general population). Mean scores for different groups of cancer sites are given separately for the three settings.
Conclusion
The detriments to QoL were stronger than in comparable studies conducted on data from clinical trials. Since these detriments were found in all three settings to a similar degree, health care providers should offer their services not only to inpatients but to outpatients and patients treated in rehabilitation clinics as well. The data can be used for QoL comparisons of assessments from different settings.
Similar content being viewed by others
References
Bottomley A, Flechtner H, Efficace F, Vanvoorden V, Coens C, Therasse P, Velikova G, Blazeby J, Greimel E (2005) Health related quality of life outcomes in cancer clinical trials. Eur J Cancer 41(12):1697–1709
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Dehaes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European-organization-for-research-and-treatment-of-cancer QLQ-C30—a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
Efficace F, Bottomley A, van Andel G (2003) Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer 97(2):377–388
Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26(8):1355–1363
Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, Liberty J (2015) Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol 26(9):1846–1858
Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von KJ, Taphoorn MJ, Weis J, Bottomley A (2011) Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst 103(24):1851–1858
Quinten C, Martinelli F, Coens C, Sprangers MAG, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A (2014) A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 120(2):302–311
Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+3). J Clin Oncol 16(3):1188–1196
Michelson H, Bolund C, Nilsson B, Brandberg Y (2000) Health-related quality of life measured by the EORTC QLQ-C30—reference values from a large sample of the Swedish population. Acta Oncol 39(4):477–484
Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351
van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK (2011) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 47(5):667–675
Derogar M, van der Schaaf M, Lagergren P (2012) Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population. Acta Oncol 51(1):10–16
Waldmann A, Schubert D, Katalinic A (2013) Normative data of the EORTC QLQ-C30 for the German population: a population-based survey. PLoS One 8(9):e74149
Juul T, Petersen MA, Holzner B, Laurberg S, Christensen P, Gronvold M (2014) Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity. Qual Life Res 23(8):2183–2193
Yun YH, Kim SH, Lee KM, Park SM, Kim YM (2007) Age, sex, and comorbidities were considered in comparing reference data for health-related quality of life in the general and cancer populations. J Clin Epidemiol 60(11):1164–1175
Finck C, Barradas S, Singer S, Zenger M, Hinz A (2012) Health related quality of life in Colombia: reference values of the EORTC QLQ-C30. Eur J Cancer Care 21(6):829–836
Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG on behalf of the EORTC Quality of Life Group (2008) EORTC QLQ-C30 Reference Values. EORTC Quality of Life Group, available at http://groups.eortc.be/qol/sites/default/files/img/newsletter/reference_values_manual2008.pdf, Bruxelles
Quinten C, Coens C, Ghislain I, Zikos E, Sprangers MA, Ringash J, Martinelli F, Ediebah DE, Maringwa J, Reeve BB, Greimel E, King MT, Bjordal K, Flechtner HH, Schmucker-Von KJ, Taphoorn MJ, Weis J, Wildiers H, Velikova G, Bottomley A (2015) The effects of age on health-related quality of life in cancer populations: a pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. Eur J Cancer 51(18):2808–2819
Mehnert A, Koch U, Schulz H, Wegscheider K, Weis J, Faller H, Keller M, Brähler E, Härter M (2012) Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients—study protocol of an epidemiological multi-center study. BMC Psychiatry 12:70
Hinz A, Singer S, Brähler E (2014) European reference values for the quality of life questionnaire EORTC QLQ-C30: results of a German investigation and a summarizing analysis of six European general population normative studies. Acta Oncol 53:958–965
Waldmann A, Pritzkuleit R, Raspe H, Katalinic A (2007) The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and-BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res 16(5):767–776
Hinz A, Einenkel J, Briest S, Stolzenburg J, Papsdorf K, Singer S (2012) Is it useful to calculate sum scores of the quality of life questionnaire EORTC QLQ-C30? Eur J Cancer Care 21:677–683
Phillips R, Gandhi M, Cheung YB, Findlay MP, Win KM, Hai HH, Yang JM, Lobo RR, Soo KC, Chow PK (2015) Summary scores captured changes in subjects’ QoL as measured by the multiple scales of the EORTC QLQ-C30. J Clin Epidemiol 68(8):895–902
Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK (2016) Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 69:79–88
Mehnert A, Brahler E, Faller H, Harter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, Wittchen HU, Koch U (2014) Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 32(31):3540–3546
Faller H, Koch U, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Szalai C, Wittchen HU, Mehnert A (2016) Satisfaction with information and unmet information needs in men and women with cancer. J Cancer Surviv 10(1):62–70
Faller H, Weis J, Koch U, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Szalai C, Wittchen H, Mehnert A (2016) Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res 81:24–30
Osoba D (1999) What has been learned from measuring health-related quality of life in clinical oncology. Eur J Cancer 35(11):1565–1570
Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29(1):89–96
Zenger M, Hinz A, Stolzenburg JU, Rabenalt R, Schwalenberg T, Schwarz R (2009) Health-related quality of life of prostate cancer patients compared to the general German population: age-specific results. Urol Int 83(2):2009–2170
Cocks K, King MT, Velikova G, de CG, Martyn St-James M, Fayers PM, Brown JM (2012) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 48(11):1713–1721
Scott NW, Fayers PM, Aaronson NK, Bottomley A, de GA, Groenvold M, Koller M, Petersen MA, Sprangers MAG (2008) The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol 61(8):788–795
Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H (2004) Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 40(5):673–680
Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2004) Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol 22(23):4829–4836
Hinz A, Mehnert A, Degi C, Reissmann DR, Schotte D, Schulte T (2017) The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients. Eur J Cancer Care 26(2):e12416
Sprangers MAG, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515
Acknowledgements
We thank all the healthcare teams that assisted in data collection at all of the participating study centers.
Funding
This study was funded by a grant from the German Cancer Aid (Grant No: 107465) within the psychosocial oncology funding priority program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the ethics committees of all participating centers.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(DOCX 58 kb)
Rights and permissions
About this article
Cite this article
Hinz, A., Weis, J., Faller, H. et al. Quality of life in cancer patients—a comparison of inpatient, outpatient, and rehabilitation settings. Support Care Cancer 26, 3533–3541 (2018). https://doi.org/10.1007/s00520-018-4211-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4211-4